Trials / Unknown
UnknownNCT02619188
Nutritional Markers in Normal and Hyperemesis Pregnancies
Pregnancy Unique Questionnaire of Emesis (PUQE) Methode Evaluation; Relation Between Rate of Nausea/Vomiting in Pregnancy (PUQE-score), Self-reported Nutritional Intake and Biochemical Nutritional Markers
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Haukeland University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study evaluate the rate of nausea and nutritional status in patients with hyperemesis gravidarum (severe nausea and vomiting in pregnancy) and healthy pregnant women using a questionnaire (PUQE-score), self-reported food/drink intake form and blood test. The Investigators aim for developing normal range of prealbumin measurements (reference values) during first trimester of pregnancy.
Detailed description
Women affected with hyperemesis gravidarum are at severe nutritional risk. Reference values for biochemical parameters evaluating nutritional status during early pregnancy needs to be determined. The investigators will compare clinical nutritional parameters (weight gain/weight loss) with rate of nausea (PUQE-questionnaire), self-reported nutritional intake form and biochemical measurements (prealbumin) in women admitted to hospital with hyperemesis gravidarum and healthy pregnant women. For hyperemesis patients measurements will be repeated at discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | PUQE-form inclusion | PUQE-form encompassing last 24 hours completion |
| OTHER | Nutritional form inclusion | Food-list form encompassing last 24 hours completion |
| OTHER | Blood sampling inclusion | Measurement of biochemical nutrition marker(s); Prealbumin |
| OTHER | Intervention at discharge | PUQE-form, nutritional form and Blood sampling |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2017-05-01
- Completion
- 2018-07-01
- First posted
- 2015-12-02
- Last updated
- 2016-10-05
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT02619188. Inclusion in this directory is not an endorsement.